DBVT DBV Technologies S.A.

NASDAQ
$11.56

DBV Technologies S.A. (DBVT) Insider Activity

What the officers, directors and large holders did with their own shares. Only open-market purchases and sales count toward the totals — grants, option exercises and shares withheld for tax are compensation mechanics, not decisions, and they're listed separately below.

Insider signal In line Selling ran in line with DBVT's own trailing one-year pace, with 0% of sale value under a prearranged plan.
Cluster activity 0 buyers in the last 30 days 0 buyers in the last 90 days 1 seller in the last 90 days
Insiders buying
0
0 transactions
Insiders selling
2
7 transactions
Purchases
$0
0 shares
Sales
$15.5M
3,378,211 shares
Net activity
-$15.5M
purchases less sales

How much of that selling was preplanned? 0% planned / 100% discretionary

10b5-1 plan sales $0 0 transactions · 0 shares
Discretionary sales $15.5M 7 transactions · 3,378,211 shares

Largest single sale: $9.9M.

Where they traded

Buy Sell Dot area is proportional to transaction value.

No open-market insider purchase on record.

Recent open-market activity

Date Insider Role Action Shares Price Value Held after
Mohideen Pharis Chief Medical Officer Sell 464 $2.70 $1.3K 144,531 −0.3% of holding
Mohideen Pharis Chief Medical Officer Sell 534 $4.86 $2.6K 144,995 −0.4% of holding
Sell 1,292,103 $4.19 $5.4M 7,303,369 −15% of holding
2 fills Sell 2,076,990 $4.85 $10.1M 8,635,472 −19.4% of holding
Mohideen Pharis Chief Medical Officer Sell 1,624 $2.77 $4.5K 101,529 −1.6% of holding
Mohideen Pharis Chief Medical Officer Sell 6,496 $2.88 $18.7K 103,153 −5.9% of holding

Form 4s are due within two business days of a transaction, so this is close to real time — unlike the quarterly 13F data on the Institutional tab. A single large sale often reflects a prearranged 10b5-1 plan rather than a fresh view, so read a pattern of sales rather than any one of them.